CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 4 Planned sale CEO and Chairman sold 9,371 shares at an average $14.06 ($131,779)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 4 Planned sale Chief Financial Officer sold 2,000 shares at an average $14.00 ($27,992)
- 4 Planned sale CEO and Chairman sold 5,029 shares at $13.99 ($70,356)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 6 of 14 · 277 filings